| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Medicine and Microbiology-Immunology and Multipurpose Arthritis Center, Northwestern University Medical School, Chicago, IL 60611
In the (SWR x NZB)F1 mouse model of lupus, we previously localized the critical autoepitopes for nephritogenic autoantibody-inducing Th cells in the core histones of nucleosomes at aa positions 10–33 of H2B and 16–39 and 71–94 of H4. A brief therapy with the peptides administered i.v. to 3-mo-old prenephritic (SWR x NZB)F1 mice that were already producing pathogenic autoantibodies markedly delayed the onset of severe lupus nephritis. Strikingly, chronic therapy with the peptides injected into 18-mo-old (SWR x NZB)F1 mice with established glomerulonephritis prolonged survival and even halted the progression of renal disease. Remarkably, tolerization with any one of the nucleosomal peptides impaired autoimmune T cell help, inhibiting the production of multiple pathogenic autoantibodies. However, cytokine production or proliferative responses to the peptides were not grossly changed by the therapy. Moreover, suppressor T cells were not detected in the treated mice. Most interestingly, the best therapeutic effect was obtained with nucleosomal peptide H416–39, which had a tolerogenic effect not only on autoimmune Th cells, but autoimmune B cells as well, because this peptide contained both T and B cell autoepitopes. These studies show that the pathogenic T and B cells of lupus, despite intrinsic defects in activation thresholds, are still susceptible to autoantigen-specific tolerogens.
This article has been cited by other articles:
|
|
 |
|
  G H Stummvoll, R D Fritsch, B Meyer, E Hoefler, M Aringer, J S Smolen, and G Steiner Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus Ann Rheum Dis, January 1, 2009; 68(1): 110 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mihaylova, E. Voynova, A. Tchorbanov, M. Nikolova, A. Michova, T. Todorov, L. Srebreva, H. Taskov, and T. Vassilev Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc{gamma}IIb receptor Int. Immunol., February 1, 2008; 20(2): 165 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-K. Kang, M. Liu, and S. K. Datta Low-Dose Peptide Tolerance Therapy of Lupus Generates Plasmacytoid Dendritic Cells That Cause Expansion of Autoantigen-Specific Regulatory T Cells and Contraction of Inflammatory Th17 Cells J. Immunol., June 15, 2007; 178(12): 7849 - 7858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-C. Tzeng, J.-L. Suen, and B.-L. Chiang Dendritic cells pulsed with apoptotic cells activate self-reactive T-cells of lupus mice both in vitro and in vivo Rheumatology, October 1, 2006; 45(10): 1230 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z-G Li, R Mu, Z-P Dai, and X-M Gao T cell vaccination in systemic lupus erythematosus with autologous activated T cells Lupus, November 1, 2005; 14(11): 884 - 889. [Abstract] [PDF]
|
|
|
|
|
|
F. Monneaux, J. Hoebeke, C. Sordet, C. Nonn, J.-P. Briand, B. Maillere, J. Sibillia, and S. Muller Selective Modulation of CD4+ T Cells from Lupus Patients by a Promiscuous, Protective Peptide Analog J. Immunol., November 1, 2005; 175(9): 5839 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Michaels, H.-K. Kang, A. Kaliyaperumal, E. Satyaraj, Y. Shi, and S. K. Datta A Defect in Deletion of Nucleosome-Specific Autoimmune T Cells in Lupus-Prone Thymus: Role of Thymic Dendritic Cells J. Immunol., November 1, 2005; 175(9): 5857 - 5865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Blank and Y. Shoenfeld Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus Rheumatology, September 1, 2005; 44(9): 1086 - 1089. [Full Text] [PDF]
|
|
|
|
|
|
G. Riemekasten and B. H. Hahn Key autoantigens in SLE Rheumatology, August 1, 2005; 44(8): 975 - 982. [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Kang, M. A. Michaels, B. R. Berner, and S. K. Datta Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets J. Immunol., March 15, 2005; 174(6): 3247 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C G Katsiari and G C Tsokos Re-establishment of tolerance: the prospect of developing specific treatment for human lupus Lupus, July 1, 2004; 13(7): 485 - 488. [PDF]
|
|
|
|
|
|
S. Fournel, S. Neichel, H. Dali, S. Farci, B. Maillere, J.-P. Briand, and S. Muller CD4+ T Cells from (New Zealand Black x New Zealand White)F1 Lupus Mice and Normal Mice Immunized Against Apoptotic Nucleosomes Recognize Similar Th Cell Epitopes in the C Terminus of Histone H3 J. Immunol., July 15, 2003; 171(2): 636 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zinger, E. Eilat, A. Meshorer, and E. Mozes Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression Int. Immunol., February 1, 2003; 15(2): 205 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasutomo Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus Rheumatology, February 1, 2003; 42(2): 214 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J W. Dieker, J van der Vlag, and J H. Berden Triggers for anti-chromatin autoantibody production in SLE Lupus, December 1, 2002; 11(12): 856 - 864. [Abstract] [PDF]
|
|
|
|
|
|
L E Schiffer, N Hussain, X Wang, W Huang, J Sinha, M Ramanujam, and A Davidson Lowering anti-dsDNA antibodies--what's new? Lupus, December 1, 2002; 11(12): 885 - 894. [Abstract] [PDF]
|
|
|
|
 |
|
 G.-C. Fan and R. R. Singh Vaccination with Minigenes Encoding VH-derived Major Histocompatibility Complex Class I-binding Epitopes Activates Cytotoxic T Cells that Ablate Autoantibody-producing B Cells and Inhibit Lupus J. Exp. Med., September 16, 2002; 196(6): 731 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Wu, F. J. Ward, and N. A. Staines Histone Peptide-Induced Nasal Tolerance: Suppression of Murine Lupus J. Immunol., July 15, 2002; 169(2): 1126 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaliyaperumal, M. A. Michaels, and S. K. Datta Naturally Processed Chromatin Peptides Reveal a Major Autoepitope That Primes Pathogenic T and B Cells of Lupus J. Immunol., March 1, 2002; 168(5): 2530 - 2537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B H Hahn Lessons in lupus: the mighty mouse Lupus, September 1, 2001; 10(9): 589 - 593. [PDF]
|
|
|
|
|
|
M R Salaman, D P. Mawer, M B Hogarth, M H Seifert, and D A Isenberg Counter-proliferative effects of nucleosomal antigens in cultures from lupus patients Lupus, May 1, 2001; 10(5): 332 - 339. [Abstract] [PDF]
|
|
|
|
 |
|
 L. M. Godsel, K. Wang, B. A. Schodin, J. S. Leon, S. D. Miller, and D. M. Engman Prevention of Autoimmune Myocarditis Through the Induction of Antigen-Specific Peripheral Immune Tolerance Circulation, March 27, 2001; 103(12): 1709 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Eilat, M. Dayan, H. Zinger, and E. Mozes The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus PNAS, January 30, 2001; 98(3): 1148 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Decker, A. Le Moal, J.-P. Briand, and S. Muller Identification of a Minimal T Cell Epitope Recognized by Antinucleosome Th Cells in the C-Terminal Region of Histone H4 J. Immunol., July 15, 2000; 165(2): 654 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Freed, A. Marrs, J. VanderWall, P. L. Cohen, and R. A. Eisenberg MHC Class II-Bound Self Peptides from Autoimmune MRL/lpr Mice Reveal Potential T Cell Epitopes for Autoantibody Production in Murine Systemic Lupus Erythematosus J. Immunol., May 1, 2000; 164(9): 4697 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
